Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Topics in Antiviral Medicine
|
December 2, 2021
HIV and Cardiovascular Disease: From Insights to Interventions
Matthew J Feinstein
Topics in Antiviral Medicine
|
January 10, 2024
Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field
Harris Avgousti, Matthew J Feinstein
Current Heart Failure Reports
|
July 15, 2022
Heart Failure in Chronic Infectious and Inflammatory Conditions: Mechanistic Insights from Clinical Heterogeneity
Nour Beydoun, Matthew J Feinstein
The Canadian Journal of Cardiology
|
March 4, 2019
Coronary Artery Disease Manifestations in HIV: What, How, and Why
Arjun Sinha, Matthew J Feinstein
Clinical Microbiology Reviews
|
February 1, 2024
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management
Ilana Nazari, Matthew J Feinstein
Current HIV/AIDS Reports
|
January 12, 2021
Immune Dysregulation in Myocardial Fibrosis, Steatosis, and Heart Failure: Current Insights from HIV and the General Population
Arjun Sinha, Matthew J Feinstein
Heart Failure Clinics
|
March 19, 2025
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus
Meilynn Shi, Matthew J Feinstein
Current Heart Failure Reports
|
June 28, 2024
Precision Phenotyping of Heart Failure in People with HIV: Early Insights and Challenges
Eli Grunblatt, Matthew J Feinstein
The Canadian Journal of Cardiology
|
February 21, 2026
Clinical knowns and mechanistic unknowns: cardioprotection and inflammation modulation of GLP-1 receptor agonists and SGLT2 inhibitors
Ellis Y Kim, Matthew J Feinstein
Current Atherosclerosis Reports
|
May 26, 2016
Monoclonal Antibodies for Lipid Management
Matthew J Feinstein, Donald M Lloyd-Jones
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Topics in Antiviral Medicine
|
December 2, 2021
HIV and Cardiovascular Disease: From Insights to Interventions
Matthew J Feinstein
Topics in Antiviral Medicine
|
January 10, 2024
Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field
Harris Avgousti, Matthew J Feinstein
Current Heart Failure Reports
|
July 15, 2022
Heart Failure in Chronic Infectious and Inflammatory Conditions: Mechanistic Insights from Clinical Heterogeneity
Nour Beydoun, Matthew J Feinstein
The Canadian Journal of Cardiology
|
March 4, 2019
Coronary Artery Disease Manifestations in HIV: What, How, and Why
Arjun Sinha, Matthew J Feinstein
Clinical Microbiology Reviews
|
February 1, 2024
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management
Ilana Nazari, Matthew J Feinstein
Current HIV/AIDS Reports
|
January 12, 2021
Immune Dysregulation in Myocardial Fibrosis, Steatosis, and Heart Failure: Current Insights from HIV and the General Population
Arjun Sinha, Matthew J Feinstein
Heart Failure Clinics
|
March 19, 2025
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus
Meilynn Shi, Matthew J Feinstein
Current Heart Failure Reports
|
June 28, 2024
Precision Phenotyping of Heart Failure in People with HIV: Early Insights and Challenges
Eli Grunblatt, Matthew J Feinstein
The Canadian Journal of Cardiology
|
February 21, 2026
Clinical knowns and mechanistic unknowns: cardioprotection and inflammation modulation of GLP-1 receptor agonists and SGLT2 inhibitors
Ellis Y Kim, Matthew J Feinstein
Current Atherosclerosis Reports
|
May 26, 2016
Monoclonal Antibodies for Lipid Management
Matthew J Feinstein, Donald M Lloyd-Jones
Page
of 9